ERA

Download the full-sized PDF of Synthetic lethal targeting of polynucleotide kinase/phosphatase and its potential role in directed cancer therapiesDownload the full-sized PDF

Analytics

Share

Permanent link (DOI): https://doi.org/10.7939/R31G0J102

Download

Export to: EndNote  |  Zotero  |  Mendeley

Communities

This file is in the following communities:

Graduate Studies and Research, Faculty of

Collections

This file is in the following collections:

Theses and Dissertations

Synthetic lethal targeting of polynucleotide kinase/phosphatase and its potential role in directed cancer therapies Open Access

Descriptions

Other title
Subject/Keyword
polynucleotide kinase/phosphatase
PTEN
synthetic lethality
SHP-1
Type of item
Thesis
Degree grantor
University of Alberta
Author or creator
Mereniuk, Todd
Supervisor and department
Weinfeld, Michael (Experimental Oncology)
Examining committee member and department
Murray, David (Experimental Oncology)
Weinfeld, Michael (Experimental Oncology)
Chan, Gordon (Experimental Oncology)
Li, Xing-Fang (Laboratory Medicine and Pathology)
Bristow, Robert (Medical Biophysics, Radiation Oncology) - University of Toronto
Department
Department of Oncology
Specialization
Experimental Oncology
Date accepted
2012-07-26T10:37:57Z
Graduation date
2012-11
Degree
Doctor of Philosophy
Degree level
Doctoral
Abstract
Synthetic lethality arises when simultaneous disruption of two non-essential, non-allelic genes in the same cell causes lethality. This phenomenon has been shown to occur between proteins involved in DNA repair and much attention to date has focused on poly(ADP-ribose) polymerase and the BRCA proteins. Synthetic lethality holds great promise in the development of tailor-made treatments for each specific patient and as such, there exists a need to expand the repertoire of known synthetic lethal associations in human cells. We intended to identify novel synthetic lethal relationships and show these lethal combinations need not solely rely on the interactions between two DNA repair proteins. We performed an siRNA screen of Qiagen’s druggable genome to identify synthetic lethal partnerships with another DNA repair protein, polynucleotide kinase/phosphatase (PNKP). We identified 14 currently known tumor suppressors showing potential synthetic lethality with PNKP, including the tyrosine-protein phosphatase SHP-1, and the major tumor suppressor PTEN. SHP-1 has been shown to be lost or diminished in ~90% of malignant prostate tissues, 95% of malignant lymphomas and 100% of NK and T cell lymphomas tested, whereas PTEN is the second most frequently lost tumor suppressor in human sporadic cancers. Therefore, targeted disruption of PNKP may be of benefit to a large subset of cancer sufferers. Further investigation into the mechanisms underlying synthetic lethality revealed that depletion of SHP-1 causes an increase in the production of reactive oxygen species. This finding suggests a possible mechanism for synthetic lethality beyond widely accepted models seen with co-disruption of PARP and the BRCA proteins in which reactive oxygen species enhance the level of unrepaired strand breaks. We also demonstrated that PTEN’s cytoplasmic phosphatase function is important to rescue the lethal phenotype upon co-disruption with PNKP. Furthermore, loss of both the 3’ phosphatase and 5’ kinase function of PNKP in double-strand break repair contribute to synthetic lethality. Since tumor suppressor proficient cells can withstand PNKP disruption, only the suppressor protein depleted cancer cells should be sensitive to PNKP inhibition. This allows for the development of a highly selective and patient-specific cancer therapy using the targeted disruption of PNKP with either a small molecule inhibitor of PNKP, or siRNA. Furthermore, since normal tissues should be minimally affected by treatment, side effects typically associated with cancer therapies should be minimized.
Language
English
DOI
doi:10.7939/R31G0J102
Rights
This thesis is made available by the University of Alberta Libraries with permission of the copyright owner solely for the purpose of private, scholarly or scientific research. This thesis, or any portion thereof, may not otherwise be copied or reproduced without the written consent of the copyright owner, except to the extent permitted by Canadian copyright law.
Citation for previous publication

File Details

Date Uploaded
Date Modified
2014-05-02T17:51:26.230+00:00
Audit Status
Audits have not yet been run on this file.
Characterization
File format: pdf (Portable Document Format)
Mime type: application/pdf
File size: 16590582
Last modified: 2016:08:08 12:52:03-06:00
Filename: Mereniuk_Todd_Fall 2012.pdf
Original checksum: 825ba232531111e109ca558888ccb184
Well formed: true
Valid: false
Status message: Invalid page tree node offset=3889
Status message: Outlines contain recursive references.
File title: Final Copy Prefatory Pages
Activity of users you follow
User Activity Date